HIV-1疫苗活病毒载体研究进展
赵怀龙,付兴伦,陈如明
摘要(Abstract):
HIV1重组活病毒载体疫苗的研究已经取得了很大进展,显示很好的应用前景,本文就近年来正在研究应用的几种HIV1疫苗活病毒载体作一综述。
关键词(KeyWords): HIV-1;病毒载体
基金项目(Foundation):
作者(Author): 赵怀龙,付兴伦,陈如明
Email:
参考文献(References):
- [1]HulskotteEG,GerettiAM,OsterhausAD.TowardsanHIV1vaccine:lessonsfromstudiesinmacaquemodels.Vaccine,1998,16:904915.
- [2]CohenJ.AIDSvaccinesshowpromiseafteryearsoffrustration.Science,2001,291:16861688.
- [3]Salmon CeronD,ExclerJL,FinkielsztejnL,etal.Safetyandimmunoge nicityofaliverecombinantcanarypoxvirusexpressingHIVtype1gp120mnmntm gag proteaseLAI(ALVAC HIV,vCP205)followedbya p24E V3MNsyntheticpeptide(CLTB36)administeredinhealthyvol unteersatlowriskforHIVinfection.AIDSResHumRetroviruses,1999,15(7):633645.
- [4]Zolla PaznerS,LubeckM,XuS,etal.Inductionofneutralizingantibod iestoTcellline adaptedandprimaryhumanimmunodeficiencyvirus type1isolateswithaprime boostvaccineregimeninchimpanzees.JVir ol,1998,72:10521059.
- [5]BruceCB,AkriggA,SharpeSA,etal.Replication deficientrecombinant adenovirusexpressingthehumanimmunodeficiencyvirusEnvantigencan inducebothhumoralandCTLimmuneresponsesinmice.JGenVirol,1999,80:26212628.
- [6]LemialeF,KongWP,AkyurekLM,etal.Enhancedmucosalimmunoglob ulinAresponseofintranasaladenoviralvectorhumanimmunodeficiency virusvaccineandlocalizationinthecentralnervoussystem.JVirol,2003,77(18):1007810087.
- [7]JohnstonRE,CaleyIJ,BettsMR,etal.Humoral,mucosal,andcellular immunityinresponsetoahumanimmunodeficiencyvirustype1immuno genexpressedbyaVenezuelanequineencephalitisvirusvaccinevector.JVirol,1997,71(4):30313038.
- [8]PaulNL,MarshM,McKeatingJA,etal.ExpressionofHIV1envelope glycoproteinsbySemlikiForestvirusvectors.AIDSResHumRetrovirus es,1993,9(10):963970.
- [9]KongW,TianC,LiuB,etal.Stableexpressionofprimaryhumanimmu nodeficiencyvirustype1structuralgeneproductsbyuseofanoncyto pathicsindbisvirusvector.JVirol,2002,76(22):1143411439.
- [10]CrottyS,LohmanBL,LuFX,etal.Mucosalimmunizationofcynomolgus macaqueswithtwosertypesoflivepoliovirussvectorsexpressingsimian immunodeficiencyvirusantigens:stimulationofhumoral,mucosaland cellularimmunity.JVirol,1999,73:94859495.
- [11]MoldoveanuZ,PorterDC,LuFX,etal.ImmuneresponsesinducedbyadministrationofencapsidatedpolioviusrepliconswhichexpressHIV1gagandenvelopeproteins.Vaccine,1995,13:10131922.
- [12]RalfA,NicolasE,MarcG,etal.Attenuatedmengovirusasavectorfor immunogenichumanimmunodeficiencyvirustype1glycoprotein120.ProcNatlAcadSci,1994,91:97759779.
- [13]DingJ,SmithAD,GeislerSC,etal.Crystalstructureofahumanrhino virusthatdisplayspartoftheHIV1V3loopandinducesneutralizing antibodiesagainstHIV1.Structure(Camb),2002,10(7):9991011.
- [14]ZhangA,GeislerSC,SmithAD,etal.Adisulfide boundHIV1V3loop sequenceonthesurfaceofhumanrhinovirus14inducesneutralizingre sponsesagainstHIV1.BiolChem,1999,380(3):365374.
- [15]HalimSS,CollinsDN,RamsinghAI.AtherapeuticHIVvaccineusing coxsackie HIVrecombinants:apossiblenewstrategy.AIDSResHum Retroviruses,2000,16(15):15511558.
- [16]McGettigenJP,FoleyHD,BelyakovIM,etal.Rabiesvirusbasedvectors expressinghumanimmunodeficiencyvirustype1(HIV1)envelopepro teininduceastrongcross reactivecytotoxicT lymohocyteresponse againstenvelopeproteinsfromdifferentHIV1isolates.JVirol,2001,75:44304434.
- [17]McGettiganJP,SarmaS,OrensteinJM,etal.Expressionandimmunoge nicityofhumanimmunodeficiencyvirustype1gagexpressedbyarepli cation competentrhabdovirusbasedvaccinevector.JVirol,2001,75(18):87248732.
- [18]McGettiganJP,PomerantzRJ,SilerCA,etal.Second generationrabies virus basedvaccinevectorsexpressinghumanimmunodeficiencyvirus type1gaghavegreatlyreducedpathogenicitybutarehighlyimmunogen ic.JVirol,2003,77(1):237244.
- [19]RoseNF,MarxPA,LuckayA,etal.AneffectiveAIDSvaccinebasedon liveattenuatedvesicularstomatitisvirusrecombinants.Cell,2001,106(5):539549.
- [20]RoseNF,RobertsA,RoseJK,etal.Glycoproteinexchangevectors basedonvesicularstomatitisvirusalloweffectiveboostingandgeneration ofneutralizingantibodiestoaprimaryisolateofhumanimmunodeficiency virustype1.JVirol,2000,74(23):1090310910.
- [21]HaglundK,LeinerI,KerksiekK,etal.Robustrecallandlong term memoryT cellresponsesinducedbyprime boostregimenswithheterolo gousliveviralvectorsexpressinghumanimmunodeficiencyvirustype1GagandEnvproteins.JVirol,2002,76(15):75067517.
- [22]FerkoB,KatingerD,GrassauerA,etal.Chimericinfluenzavirusrepli catingpredominantlyinthemurineupperrespiratorytractinduceslocal immuneresponsesagainsthumanimmunodeficiencyvirustype1inthe genitaltract.JInfectDis,1998,178:13591368.
- [23]MurphyCG,LucasWT,MeansRE,etal.Vaccineprotectionagainst simianimmunodeficiencyvirusbyrecombinantstrainsofherpessimplex virus.JVirol,2000,74(16):77457754.
- [24]McKeeHJ,StrayerDS.ImmuneresponsesagainstSIVenvelopeglycop roteinusingrecombinantSV40asavaccinedeliveryvector.Vaccine,2002,20(2930):36133625.
- [25]CasimiroDR,ChenL,FuTM,etal.Comparativeimmunogenicityin rhesusmonkeysofDNAplasmid,recombinantvacciniavirus,andrepli cation defectiveadenovirusvectorsexpressingahumanimmunodeficiency virustype1gaggene.JVirol,2003,77(11):63056313.